Bellevue Group Ag Sight Sciences, Inc. Transaction History

Bellevue Group Ag

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$8.44 - $13.35 $70,237 - $111,098	-8,322 Reduced 2.82%	286,284 $2.5 Million
Q2 2022 Aug 11, 2022	SELL	$6.61 - $11.99 $35,654 - $64,674	-5,394 Reduced 1.8%	294,606 $2.65 Million
Q3 2021 Nov 12, 2021	BUY	$22.34 - $39.1 $6.7 Million - $11.7 Million	300,000 New	300,000 $6.81 Million

21.1M

33.2K

27.7K

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $296M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.